Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study. [electronic resource]
Producer: 20190814Description: 35-43 p. digitalISSN:- 1365-2036
- 2-Naphthylamine
- Aged
- Anilides -- administration & dosage
- Antiviral Agents -- therapeutic use
- Benzimidazoles -- administration & dosage
- Carbamates -- administration & dosage
- Case-Control Studies
- Cyclopropanes
- Drug Therapy, Combination
- Electronic Health Records -- statistics & numerical data
- Female
- Fluorenes -- administration & dosage
- Glomerular Filtration Rate -- drug effects
- Hepatitis C, Chronic -- complications
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- administration & dosage
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Renal Insufficiency, Chronic -- complications
- Retrospective Studies
- Ritonavir -- administration & dosage
- Sofosbuvir
- Sulfonamides -- administration & dosage
- Sustained Virologic Response
- Treatment Outcome
- Uracil -- administration & dosage
- Uridine Monophosphate -- administration & dosage
- Valine
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.